10x Genomics NASDAQ: TXG reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to emphasize the launch of Atera, a new spatial biology instrument platform that management described as the most significant product introduction in the company’s history.Chief Executive Officer and Co-Founder Serge Saxonov said the company had a “really nice start to the year,” citing sales momentum, product launches and execution. Revenue for the quarter ended March 31, 20 ...